Form 8-K - Current report:
SEC Accession No. 0001326190-24-000042
Filing Date
2024-09-26
Accepted
2024-09-26 16:45:34
Documents
13
Period of Report
2024-09-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K alt-20240926x8k.htm   iXBRL 8-K 76458
  Complete submission text file 0001326190-24-000042.txt   198266

Data Files

Seq Description Document Type Size
2 EX-101.SCH alt-20240926.xsd EX-101.SCH 3267
3 EX-101.LAB alt-20240926_lab.xml EX-101.LAB 15900
4 EX-101.PRE alt-20240926_pre.xml EX-101.PRE 10113
15 EXTRACTED XBRL INSTANCE DOCUMENT alt-20240926x8k_htm.xml XML 4868
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 241329532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)